SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jenburkt Pharmaceuticals informs about loss of share certificate

11 Aug 2020 Evaluate

Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and disclosure Requirements) Regulations, 2015, Jenburkt Pharmaceuticals has informed about the loss of share certificate(s) received details as enclosed. The company is in the process of issuing duplicate share certificate, after compliance of required formalities. The company has informed the members of the Exchange, with instructions that they communicate to them immediately if they are in a position to give them information relating to any transaction or whereabouts of the above referred original share certificate.

The above information is a part of company’s filings submitted to BSE.


Jenburkt Pharma Share Price

1114.65 13.35 (1.21%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: